Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PRCT

PRCT - PROCEPT BioRobotics Corporation Stock Price, Fair Value and News

$27.15+1.03 (+3.94%)
Delayed

52/100

PRCT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

52/100

PRCT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PRCT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PRCT Price Action

Last 7 days

12.1%

Last 30 days

-4.7%

Last 90 days

-24.6%

Trailing 12 Months

-51.5%

PRCT RSI Chart

PRCT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PRCT Valuation

Market Cap

1.5B

Price/Earnings (Trailing)

-16.02

Price/Sales (Trailing)

4.97

EV/EBITDA

-15.15

Price/Free Cashflow

-26.24

PRCT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PRCT Fundamentals

PRCT Revenue

Revenue (TTM)

308.1M

Rev. Growth (Yr)

11.94%

Rev. Growth (Qtr)

-8.33%

PRCT Earnings

Earnings (TTM)

-95.6M

Earnings Growth (Yr)

-58.28%

Earnings Growth (Qtr)

-39.39%

PRCT Profitability

Operating Margin

63.70%

EBT Margin

-30.96%

Return on Equity

-26.12%

Return on Assets

-18.81%

Free Cashflow Yield

-3.81%

PRCT Investor Care

Shares Dilution (1Y)

2.87%

Diluted EPS (TTM)

-1.71

PRCT Alerts

  • 1 major insider buys and 2 major insider sales recently.
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025249.1M274.9M299.9M308.1M
2024156.3M176.6M199.8M224.5M
202385.2M101.6M116.4M136.2M
202241.5M49.7M61.4M75.0M
202114.4M21.1M27.8M34.5M
20200007.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About PROCEPT BioRobotics Corporation

PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
 CEO
 WEBSITEprocept-biorobotics.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES428

PROCEPT BioRobotics Corporation Frequently Asked Questions

PRCT is the stock ticker symbol of PROCEPT BioRobotics Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of PROCEPT BioRobotics Corporation is 1.53 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, PRCT's PE ratio (Price to Earnings) is -16.02 and Price to Sales (PS) ratio is 4.97. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRCT PE ratio will change depending on the future growth rate expectations of investors.